BrainStorm

March 31, 2014

How Close Are We to an Approved Treatment? - Bernard Munos

Thumbnail

How Close Are We to an Approved Treatment? - Bernard Munos

About This Episode

A discussion with Bernard Munos, Founder of InnoThink, and named one of the 25 most influential people in biopharma by FiercePharma.  He discussed his analysis of the drug pipeline, the status of drugs in it, as well as his recommendations for how we can organize research more effectively and lower the cost of innovation and reduce the risk of failure so that we can get to a cure faster and at lower cost.

This call was made possible by the generous support of the Zickler Family Foundation.

BrainStorm Feed

104
March 3, 2026 | 27:17

Promoted and Caregiving - The Reality Young Professionals Don't Talk About

What happens when your carefully mapped career path collides with an Alzheimer's diagnosis — and you're only 26? In this deeply personal episode of BrainStorm

LISTEN NOW
103
February 17, 2026 | 23:13

Chipping Away at the Crisis - A New Era in Alzheimer's Diagnosis and Treatment with Dr. Jason Karlawish

Alzheimer's disease is no longer just a memory problem — it's a biological, cultural, and ethical challenge reshaping how we think about aging, identity, and

LISTEN NOW
102
February 3, 2026 | 25:17

Bridging the Gap: Nurses Leading the Fight for Alzheimer's Health Equity

In honor of Black History Month, this episode of BrainStorm by UsAgainstAlzheimer’s explores the critical intersection of Alzheimer's disease and health equity in African-American communities

LISTEN NOW